Hansjoerg Eibl
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
-
- Lipid Membrane Structure and Behavior
- RNA Interference and Gene Delivery
- Protein Structure and Dynamics
Papers in
-
- Lipid Membrane Structure and Behavior 5
- RNA Interference and Gene Delivery 3
- Peroxisome Proliferator-Activated Receptors 1
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Karl Harlos (3 shared papers)Lars H. Lindner (6 shared papers)Rolf D. Issels (3 shared papers)M. Schmitt‐Sody (1 shared paper)Marc Dellian (1 shared paper)Martin Eichhorn (1 shared paper)Horst Vogel (1 shared paper)Wolfgang Hiddemann (2 shared papers)
- Journals
- Biochemistry (4 papers)Journal of Controlled Release (2 papers)Clinical Cancer Research (1 paper)European Journal of Cancer (1 paper)Contrast Media & Molecular Imaging (1 paper)
- Partner nations
- GermanyUnited States
In The Last Decade
Hansjoerg Eibl
13 papers receiving 633 citations
Peers
Comparison fields: 5 of 83
- Biomaterials 221
- Molecular Biology 446
- Pharmaceutical Science 32
- Biochemistry 30
- Filtration and Separation 8
Countries citing papers authored by Hansjoerg Eibl
This map shows the geographic impact of Hansjoerg Eibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hansjoerg Eibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hansjoerg Eibl more than expected).
Fields of papers citing papers by Hansjoerg Eibl
This network shows the impact of papers produced by Hansjoerg Eibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hansjoerg Eibl. The network helps show where Hansjoerg Eibl may publish in the future.
Co-authors
The 25 scholars most cited alongside Hansjoerg Eibl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 206 | |
| 2 | 1979 | 105 | |
| 3 | 1981 | 105 | |
| 4 | 2007 | 60 | |
| 5 | 1980 | 56 | |
| 6 | 2007 | 31 | |
| 7 | 1993 | 24 | |
| 8 | 2008 | 23 | |
| 9 | 2010 | 22 | |
| 10 | 2005 | 17 | |
| 11 | 1987 | 13 | |
| 12 | 1993 | 10 | |
| 13 | 1984 | 6 |
About Hansjoerg Eibl
Hansjoerg Eibl is a scholar working on Molecular Biology, Biomaterials, Organic Chemistry, Oncology and Physical and Theoretical Chemistry, having authored 13 papers that have together received 678 indexed citations. Recurring topics across this work include Lipid Membrane Structure and Behavior (5 papers), Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (3 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Acute Myeloid Leukemia Research (1 paper), Microbial Inactivation Methods (1 paper), Acute Lymphoblastic Leukemia research (1 paper) and Molecular Sensors and Ion Detection (1 paper). The work is most often cited by research in Biomaterials (221 citations), Molecular Biology (446 citations), Pharmaceutical Science (32 citations), Biochemistry (30 citations) and Filtration and Separation (8 citations). Hansjoerg Eibl has collaborated with scholars based in Germany and United States. Frequent co-authors include Karl Harlos, Lars H. Lindner, Rolf D. Issels, M. Schmitt‐Sody, Marc Dellian, Martin Eichhorn, Horst Vogel, Wolfgang Hiddemann, Clemens Unger and Martin Hossann. Their work appears in journals such as Biochemistry, Journal of Controlled Release, Clinical Cancer Research, European Journal of Cancer and Contrast Media & Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.